Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INSIGHT-IBD Pragmatic Study: Investigation of Mirikizumab in Real World Settings for Mirikizumab

NCT07686757 is registered in ClinicalTrials.gov with Specialty Networks Research. as lead sponsor.

NCT NCT07686757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07686757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INSIGHT-IBD Pragmatic Study: Investigation of Mirikizumab in Real World Settings for Mirikizumab
Lead sponsor
Specialty Networks Research.
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
August 12, 2026
Completion date
June 30, 2028
Enrollment
400 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease (cd), ulcerative colitis (uc)